Ignite Creation Date:
2025-12-24 @ 11:58 AM
Ignite Modification Date:
2025-12-28 @ 12:11 PM
Study NCT ID:
NCT00417261
Status:
COMPLETED
Last Update Posted:
2008-06-23
First Post:
2006-12-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2008-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-28
First Submit QC Date:
None
Study First Post Date:
2006-12-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-06-20
Last Update Post Date:
2008-06-23
Last Update Post Date Type:
ESTIMATED